Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia
Clinical trial NCT01439971 · COMPLETED
Trial details
- NCT number
- NCT01439971
- Sponsor
- Catalyst Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-10-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.